3-CMC Stats & Data

3-CMC first appeared in 2014, emerging as part of the broader wave of synthetic cathinones entering the European designer drug market during this period. The substance was primarily sold through online vendors, with initial distribution concentrated in Germany, Poland, the Netherlands, and Sweden. Over the following years, 3-CMC spread across the continent, eventually being detected in 25 European countries. Poland became the region with the highest number of seizures, while the Netherlands accounted for the largest quantities identified. Annual seizure data from 2014 to 2021 demonstrated a consistent increase, indicating growing production and availability throughout this period. Production sources shifted over time. While early supplies originated primarily from China, manufacturing subsequently relocated to India following regulatory changes in the former country. Customs authorities have since identified Indian sources as the origin for large-scale imports into Europe, with little production documented as occurring within European borders.

3-CMC's isomer 4-CMC is a known neurotoxin, and research shows that 3-CMC is neurotoxic in mice. If 3-CMC's mechanism of action is inherently neurotoxic then damage to human health may be incurred even at moderate recreational doses. Anecdotal reports mention highly concerning cardiovascular and neurological symptoms after frequent or high-dose use, which seems to confirm this suspicion. It is strongly advised to avoid this substance completely. Use excessive harm reduction practices if planning on using this substance, and avoid redosing.

From 4 individual dose entries

Most common forms and preparations reported